Home
Live Updates
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript : comparemela.com
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q1 2022 Results - Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:NASDAQ:HRTX) Q1 2022 Results Conference Call May 09, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John...
Related Keywords
Canada ,
Josh Schimmer ,
Serge Belanger ,
John Poyhonen ,
David Szekeres ,
Kimberly Manhard ,
Kelly Shi ,
Brandon Folkes ,
Company Participants ,
Cantor Fitzgerald ,
Heron Therapeutics Inc ,
Symphony Health ,
Nasdaq ,
Drug Development ,
Heron Therapeutics ,
Conference Call May ,
Chief Commercial ,
Heron Therapeutics First Quarter ,
Executive Vice President ,
Chief Operating ,
Barry Quart ,
Chief Executive Officer ,
Chief Commercial Officer ,
Investor Relations ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.